We examined the effects of retinoic acid (RA), 1, 25-dihydroxyvitamin D
3 (1, 25-(OH)
2D
3), and its synthetic analogue, 22-oxa-1, 25-(OH)
2D
3, on differentiation of U937 cells by studying the cellular growth, surface marker expression and cytosolic free Ca
2+ concentration ([Ca
2+]
i). RA inhibited cellular growth but did not induce expression of Mo2 (CD14), a monocyte/macrophage specific surface marker. To the contrary, 1, 25-(OH)
2D
3 did not inhibit cellular growth, but increased CD14-positive cells. Simultaneous addition of 1, 25-(OH)
2D
3 and RA had no additive effect on cellular growth inhibition or CD14 expression. With regard to [Ca
2+]
i, however, 5 days' incubation with either of them increased the basal [Ca
2+]
i level and induced U937 cells to respond to formyl-methionyl-leucyl-phenylalanine (FMLP). When the cells were incubated with both 10
-6M RA and 10
-8M 1, 25-(OH)
2D
3, basal [Ca
2+]
i was higher and FMLP caused a greater increase in [Ca
2+]
i than when only RA or 1, 25-(OH)
2D
3 was added. These data suggest that RA and 1, 25-(OH)
2D
3 induce monocytoid differentiation in U937 cells through different pathways and act synergistically in the differentiation process. The 22-oxa-1, 25-(OH)
2D
3 induced CD14 expression, basal [Ca
2+]
i increase and [Ca
2+]
i response to FMLP, but did not cause cellular growth inhibition in U937 cells, and in these points, 22-oxa-1, 25-(OH)
2D
3 exhibited no significantly different effects from 1, 25-(OH)
2D
3. Thus, 22-oxa-1, 25-(OH)
2D
3 has the same potent activity as 1, 25-(OH)
2D
3 in inducing differentiation of U937 cells.
View full abstract